Background and Purpose-To maximize the benefits of thrombolysis, it is necessary not only to treat more patients, but to deliver treatment as early as possible. The aims of our study were to prospectively evaluate the clinical benefit from reducing delays in the emergency stroke pathway at our district hospital and examine outcomes from scenarios that include extension of the alteplase license. Methods-We developed a discrete-event simulation from prospective data for patients with stroke arriving at our large district hospital. We modeled current practice and assessed the impact on stroke outcomes of measures to reduce in-hospital delays to alteplase treatment and of extensions to the European license for alteplase from 3 to 4.5 hours and to people aged Ͼ80 years. Results-Extension of the time window to 4.5 hours increases the thrombolysis rate by 4%, yielding an additional 2 patients per year with minimal or no disability at 3 months. Time window extension is most effective when combined with a system of prealerts, achieving a thrombolysis rate of 15% and an additional 8 patients per year with minimal or no disability, increasing to 13 patients per year with extension of the license to patients Ͼ80 years. Conclusions-If implemented alone, extension of the time window for alteplase has only a modest additional population disability benefit, but this benefit can be increased 5-fold if time window extension is combined with substantial reductions to in-hospital delays. (Stroke. 2012;43:00-00.)
C urrently, the only licensed treatment worldwide for acute ischemic stroke is thrombolysis with intravenous alteplase. 1 The benefit from alteplase is critically dependent on the time to treatment with an exponential decay in the odds of a favorable outcome from one 90-minute interval to the next up to 4.5 hours. 2 However, 16 years after first licensing in the United States, the uptake of alteplase remains limited in most countries. The latest large US and European data sets show rates of thrombolysis of 4.3% to 10% of patients with ischemic stroke, [3] [4] [5] [6] and average onset-to-treatment times have not substantially reduced over time. 3, 5 Moreover, the latest Swedish national registry data indicate that the greatest growth in the numbers of patients treated has come from those treated between 3 and 4.5 hours, 3, 7 when the odds of a favorable outcome are considerably lower than with earlier treatment. 1, 2 This steep gradient of benefit is a particular issue given the frequently reported observation of longer arrivalto-treatment times for patients who arrive at the hospital earlier, 5, 6, 8, 9 an effect that may be exacerbated by removal of the 3-hour treatment deadline. 10 Studies have shown that a coordinated approach to reducing in-hospital treatment delays can significantly increase the proportion of patients treated, 11 yet the Get With The Guidelines-Stroke data from Ͼ25 000 patients from Ͼ1000 centers in the United States show only a small trend toward reduced in-hospital treatment times over the period 2003 to 2009 and a mean arrival-to-treatment time of 79 minutes. 12 To maximize the benefits from alteplase in reducing disabling stroke, a greater emphasis is required on treating all patients much earlier 11, 13 and in this regard, current recommendations for US emergency departments (EDs) to complete the assessment and imaging of eligible patients within 1 hour of arrival may be too lenient, 14 a target achieved, in any event, in only 18% of patients who arrive within the first "golden" hour after known symptom onset. 5 Our modeling study, based on a large prospective data set of patients with acute stroke arriving at a large mixed rural-urban district (community) hospital, sought to examine the factors that were most critical to improving disability outcomes after thrombolysis through not only increasing the proportion of patients treated with alteplase, but also through achieving substantial reductions in the in-hospital delays to treatment.
Methods
We developed a discrete-event simulation based on prospective data for patients with stroke arriving at our hospital, which receives 600 cases of acute stroke per year. The discrete-event simulation was restricted to the emergency thrombolysis pathway: modeling the times from onset to arrival in the ED for triage and assessment, brain imaging, and, if applicable, thrombolysis. We sought to model current practice and compare it with scenarios exploring the impact of European license extension from 3 to 4.5 hours and to patients aged Ͼ80 years, of ED staff alerting the stroke service at triage, of ambulance prealert to the stroke team, and combinations of these measures.
Simulation Model
Emergency treatment pathways incorporate a great deal of variation in arrival-to-treatment times due to hospital workload, clinical decisionmaking, and other factors. Discrete-event simulation is an appropriate method for modeling such processes and is used extensively in service modeling, healthcare applications, [15] [16] [17] [18] and high-level stroke modeling. 19, 20 Variation in processing times, decision-making, arrival rates, and the first point of referral to the Acute Stroke Team (AST) are incorporated into the model through probability distributions derived from empirical data. The simulation software (SIMUL8; SIMUL8 Corporation, Boston, MA; www.Simul8. com) also provides animation to improve accessibility to clinicians and the ability to communicate causes and solutions for delays in the emergency pathway. For a detailed modeling protocol including validation, see online-only Data Supplement.
The delivery of thrombolysis at our hospital is the responsibility of an AST rather than ED physicians, but the patient pathway involves multiple departments including the regional ambulance service and the ED, particularly for triage using the Recognition of Stroke in the Emergency Room (ROSIER) tool. 21 The AST consists of advanced nurse practitioners using a standardized assessment protocol over an extended working day plus the stroke physician on call. To model the coordination between the various elements of the pathway accurately, the simulation incorporated the time-sensitive aspects of the pathway such as variation in workload and competing clinical demands in the ED, the speed of communication between elements of the pathway, and differences between office hours and out-ofhours working, including radiology. These details were adjustable across a 24-hour day and a 7-day week.
Outcome Measures
Outcome measures were related to clinical performance or to workload at our hospital. Clinical performance includes the percentage of all strokes cases thrombolyzed, patients treated by onset-totreatment time interval, and disability outcomes at 90 days that are attributable to treatment dichotomized between a modified Rankin Scale score of 0 to 1 ("favorable outcome" with minimal or no disability) and 2 to 6 ("unfavorable outcome" indicating survival with significant disability or death). Workload estimated the number of urgent AST and radiology (CT) callouts. The latter was included because although all patients with potential stroke receive brain imaging, for "real-world" application, it was important to quantify the number that is prioritized over other emergency patients.
Data Sources
We populated the model using anonymized audit data routinely collected as part of hospital performance monitoring. Because no single data set met all of the requirements necessary for a model of this level of detail, multiple sources were used; Table 1 lists the data sources and their use within the model. Table 2 lists the 5 scenarios selected for the study, although others were examined and discarded. Scenarios are run multiple times for a period of 1 year (nϭ100). Differences in the average performance of scenarios are compared using paired t CIs adjusted for multiple comparisons using the Bonferroni correction. The mean difference in thrombolysis rates between scenario i and j is denoted as X i,j and the mean difference in additional patients with modified Rankin Scale 0 to 1 as Z i,j , in which scenario 0 represents current practice.
Scenario Comparison

Results
Clinical Performance
For each scenario, Table 3 ‫;4.4؍‬ 99% CI 4.1-4.9), favorable patient outcomes above extension of the treatment window, respectively. A combination of the prealert system with an extended license increases thrombolysis by a further 4% (X 3, 4 ϭ4.5%; 99% CI, 4.1-4.7) and adds 2 further favorable outcomes (Z 3, 4 ϭ1.7; 99% CI, 1.5-2.1). The final scenario combines the prealert system and license extension incorporating both treatment up to 4.5 hours and the treatment of patients Ͼ80 years. The thrombolysis rate reaches 23%, and a favorable outcome is achieved in an additional 13 patients (Z 0,5 ϭ12.9; 99% CI, 12.4 -13.4) compared with current practice. Table 3 also shows the increased workload in each scenario. Current practice of referral from the ED averages 100 urgent assessments by the AST per annum. License extension increases the number referred urgently to Ͼ150 per year with 75% requiring a prioritized scan. Urgent assessments increase approximately 4-fold to nearly 350 per annum in the scenarios implementing any prealert. The difference between urgent assessments and prioritized scans in scenarios 1 to 4 is explained largely by patients exceeding the current upper age limit for the European alteplase license.
Urgent Workload
Sensitivity Analysis
The scenarios exploring prealert of patients to the AST assume 100% compliance during triage and ambulance travel. To quantify the uncertainty of our outputs, we performed a sensitivity analysis of compliance rates using a 2ϫ2 factorial experimental design modeling a poor compliance rate of 30% and a good compliance rate of 80%. Table 4 lists the results. Clinical performance is most sensitive to poor compliance by both triage and paramedics. The disability benefit is relatively robust so long as one of the compliance rates remains high. Additional sensitivity analyses including patients with an unknown onset in the early hours of the day (see the online-only Data Supplement) have minimal further effect on outcomes.
Discussion
Our modeling study quantifies the potential benefits from reducing delays to alteplase treatment within the emergency pathway not simply in terms of the numbers of patients treated, but uniquely in terms of patients surviving with a favorable outcome. European practice involves an increasing proportion of patients treated beyond 3 hours, 24 but although modeling demonstrates the tangible benefit from extending the treatment window from 3 to 4.5 hours, to do so without simultaneously reducing in-hospital delays may result in only a very modest population benefit or even none at all. 10 Our model demonstrates that the increase in thrombolysis rates from time window extension alone pales in comparison to the population benefit from treating all patients more quickly. Policies for the referral of patients with potential stroke at triage or by ambulance prealerts are often cited as controllable methods for reducing in-hospital treatment delays. 25, 26 Implementation of these policies in our hospital offers the prospect of a 4-fold increase in thrombolysis rates and, because of much earlier treatment, a 5-fold increase in additional patients with no or minimal symptoms at 90 days. Assuming reasonable compliance by either ambulance paramedics or ED triage, the increase in thrombolysis rates to 13% to 15% in our model is similar to what others have 
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considered could be achievable in the United Kingdom 27 and far exceeds national targets that at the time were considered by some as unfeasibly optimistic. 28 The latest evidence on the risks and benefits of alteplase 29, 30 supports the validity of the scenario evaluating the removal of the upper age limit for the European license, particularly for patients treated within 3 hours. Given the uncertainties regarding efficacy in older patients beyond 3 hours, we urge caution when interpreting the results for patients Ͼ80 years treated between 3 to 4.5 hours. We note the relative robustness of our results, however, when compared with the scenario exploring prealerts combined with an extended treatment window. In fact, the 3-to 4.5-hour subgroup adds only a single extra patient with a favorable outcome at our hospital. In contrast to traditional methods of top-down targetdriven service improvement, the strengths of this modeling approach are 2-fold. First, it provides a quantitative evaluation of the impact of change on the thrombolysis pathway that is risk-free; in contrast to a lengthy process of "trial and error" coupled with labor-intensive evaluation, simulation can use routinely collected hospital performance data to test a wide range of scenarios in a fraction of the time, quantifying the tangible benefits of those that are effective and discarding those that are not. This approach also allows for the modeling of unintended consequences such as increased callouts for the AST and the displacement of other emergency imaging activity. These considerations are often missing from simpler improvement models, yet in reality, they often contribute to organizational inertia and resistance to change, and our modeling approach allows for these issues to be made explicit and specifically addressed. Second, the model contains overt assumptions and data that can be challenged and explored by clinicians, increasing the "real-world" validity of the outputs, which are quantified in terms of tangible benefits to patients: the number of additional patients per year with no or minimal disability 3 months after stroke. This latter feature is particularly important if the clinicians and departments involved in the pathway are to embrace and implement change. The face validity of simulation, backed up by animations and patientfocused outcomes, can provide the impetus for clinicians to overcome organizational inertia and pursue targeted improvements in service delivery. 25 What is more, simulation using center-specific data allows the development of bespoke solutions to the differing organizational obstacles of hospitals with different pathways for thrombolysis, moving away from the "one size fits all" notion that similar measures will automatically yield similar benefits regardless of the context. Site-specific simulation such as that used in our study may be one means to address the disappointing lack of progress in increasing the thrombolysis rate and reducing arrival-totreatment times in a broad range of US hospitals over recent years despite nationwide initiatives such as Get with the Guidelines. 12 
Limitations
A particular issue with the model is that we are unable to fully model the impact of patients who arrive with symptoms that mimic stroke. Because the specificity of the ROSIER assessment may be as low as 44%, 22 we knew that our estimates of additional urgent AST callouts and imaging are at the lower limits of what may happen in practice. In seeking to engage other departments with the process of organizational change, an excess false-positive rate may act as a disincentive to change. To deal with other areas of uncertainty in the model, we conducted a comprehensive sensitivity analysis of input factors, showing that a drop in compliance with prealerts has the greatest impact on patient outcomes. The implementation of a prealert system must be sustainable and robust with data feedback to support practice change in the ambulance service. 31 Our model shows that a safeguard against low compliance would be the use of the ROSIER assessment by both ambulance staff and ED triage, which was not associated with a penalty in disability outcomes.
An extension of our model might incorporate the prehospital emergency phase in greater detail. Data from the local ambulance service indicate that reductions could be made in the time paramedics spend at a stroke incident (median, 24 minutes; interquartile range, 15.5 minutes). Although to some extent this factor is controllable, it is also inherently variable. As such, to improve disability outcomes, we recommend similar studies focus on the controllable in-hospital factors that delay thrombolysis treatment. By the same token, we have not modeled alterations in public behavior in the recognition of stroke symptoms, which have been the target of national public education campaigns, although the impact of these measures has been disappointing. 4 
Conclusions
Our modeling study is the first to quantify the disability benefit from substantial changes to the in-hospital treatment pathway to increase the proportion of people with stroke receiving alteplase treatment and at an earlier time from onset. Modeling alone is not enough to achieve change within healthcare systems and it remains critically important to engage with the ambulance service, radiologists, and ED physicians to reach a consensus on action. Nonetheless, a operational model such as ours provides a powerful lever to overcome inertia in the dissemination of primary research and in implementing organizational change. Studies such as ours should reinvigorate the pursuit of improved organizational and clinical performance in the emergency care of acute ischemic stroke and specifically the amendment of existing service specifications and targets 14 to optimize the delivery of time-critical treatment with alteplase.
Sources of Funding
This article presents independent research funded by the National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care (CLAHRC). The views expressed in this publication are those of the author(s) and not necessarily those of the National Health Service, the NIHR, or the Department of Health.
Disclosures
None.
Introduction
The main article provides a summary of the most important results of the study along with discussion of the clinical importance. This online supplement provides further details of the discrete-event simulation (DES) model used including methodology, quantitative model validation and sensitivity analysis of model results.
Supplementary Methods
Analysis Software
The simulation model was developed using Simul8 Professional 2010 (SIMUL8; SIMUL8 Corporation, Boston MA; http://www.Simul8.com). Input modelling of time distributions was conducted using maximum likelihood parameter estimates produced by Stat:fit (Stat:fit; Geer Mountain Software Corporation, South Kent Connecticut; http://www.geerms.com).
Sampling Methodology
Simul8 uses the Mersenne Twister for generation of uniformly distributed [0,1] psuedo random numbers and provides common random number streams for variance reduction and synchronisation between scenarios. Event handling is managed by the three phase approach. Time dependent processing durations within the system, e.g. varying demand levels in the emergency department (ED), are handled by Simul8's time dependent distributions that vary parameters by simulated clock time. Multiple independent replications are used to estimate mean performance of the system along with corresponding 95% confidence intervals. A total of 100 replications are used to achieve a 95% confidence interval half width below 5% of the mean. Figure S1 provides a simplified overview of the pathway, in normal working hours, included in the model. The pathway is divided into four sections, a pre-hospital phase, an emergency department (ED) phase, an information exchange phase and a phase where the acute stroke team (AST) takes responsibility for the patient. The longest route through the pathway is to travel all the way through the ED process before being referred to the AST. However, as the local ambulance service performs a FAST test on route to hospital the potential exists to use this information to bypass some of the delays within the emergency department (represented as dotted lines in Figure S1 ). In particular, if the ambulance paramedics pre-alert the ED about the imminent arrival of a FAST positive patient and this information is passed on then a.) Stroke Nurse Practitioners (SNP) can meet the patient in the emergency room on arrival, and b.) Radiology services can be warned of an urgent thrombolysis possibility and allocate CT resources at the appropriate time.
Model Logic
At the time the study began the likelihood of the AST receiving a pre-alert via ED was low (9%). An alternative early referral strategy also in use was early referral of FAST positive patients after nurse triage (9%). Although this is not as fast as a pre-alert, referral after triage still bypasses a potentially lengthy wait for an ED medic and ED assessment before referral. We also found that the AST received alerts via process flow coordinators as a patient registered in ED; although this was relatively rare (3%). We modelled ED medic decision making, i.e. should a patient activate the AST thrombolysis pathway, using a set of simple decision making rules: a.) was (known) onset less than three hours ago; b.) is the patient's age less than 80 years, c.) what is the probability that the patient has further contra-indications. Patients that do not pass these criteria are referred to the hospital's acute medical unit (AMU) to await transfer to the acute stroke unit.
Once the patient information has been passed to the AST, the patient waits in ED until a SNP can attend. This is followed by a specialist assessment and a further eligibility decision based on time from onset and age. If this is positive the patient is prioritised for a CT scan (scanners are located next to the ED) and waits while a radiologist reports the results to a consultant stroke physician.
There is then a final round of decision making, this time by a consultant stroke physician, and a small delay while the alteplase infusion is prepared for eligible patients.
Out of hours logic is extended to include further delays due to; a) contact time for radiographers and consultant stroke physicians; b) travel times to hospital, c) time for CT scanners to come online and time for radiologist to remotely report on scan results. 4. Check the conceptual usage of the distribution selected; Table S1 details the probability distributions used to represent variation in processing times within the simulation model. Note that many of the parameters for these distributions will vary by hospital, due to population demographics, hospital size and staffing levels. 19:00-00:00 µ=20 Quantitative validation of the model Table S2 presents the characteristics of patients included in the sample used to build the model. In total there were 1142 strokes that arrived as emergency admissions of which 77% (95CI 74.4% -79.3%) were ischemic. The third column provides a comparison to the rt-pa arm of the third International Stroke Trial (IST3). Comparison between proportions were conducted using a two proportion z-test. Proportions were very similar between age, sex and stroke severity and there was insufficient evidence to conclude that differences were due to anything but chance alone. Patients that were thrombolysed within the 3 hour European license had relatively low onset to arrival (OTA) (median = 58.0 minutes, IQR = 38.0) i.e. as observed elsewhere patients were more likely to undergo thrombolysis if they arrived within the first golden hour 1 .
Onset of symptoms
Representativeness of Patient Sample
Arrival Profile of Stroke Patients
A key determinant for the configuration of thrombolysis services is the arrival profile of potential stroke patients across a weekday. As part of our wider analysis, we filtered our hospital emergency department database for patients diagnosed with stroke at discharge over a two year period (n = 1142).
To model our observed pattern we fitted probability distributions to the sample of arrival times and then compared simulated output and our observed sample to another source of the acute stroke arrival profile taken from the to the Stroke National Improvement Programme (SINAP n = 47,550 after inpatients were excluded). Figure S2 illustrates the cumulative arrival profile of patients by time of day across the three data sources. Table S3 compares the breakdown of arrival to scan time (ATS), arrival to treatment time (ATT), and onset to treatment time (OTT) from an audit sample of the current situation to the simulated results.
All simulated outcomes fall within the 95% confidence intervals for the audit sample. Additionally,
we conducted a sensitivity analysis on the point of referral of a potential stroke to the acute stroke team (AST). The model was most sensitive to the proportion of pre-alerts of imminent stroke arrivals received by the AST either directly or via the ED. To address this uncertainty we conducted a further analysis of results in the scenarios incorporating pre-alerts to assess the sensitivity of outcomes to differing levels of compliance. 
Supplementary Results
Sensitivity Analysis
In addition to the analysis of compliance in the main text we also consider the proportion of patients with contra-indications across a day. As patient presentations are fewer in the early hours of the day (01:00 to 09:00) and are not necessarily referred urgently to the AST, we had some concern that the proportion of patients with no known time of onset might be underestimated in the model. Figure S3 illustrates the average thrombolysis rates if the proportion of patients with contra-indications, other than time and patient age, is increased in the early hours of the ambulance pre-alert scenario (scenario 3). Four levels of underestimation, 5% -20%, are shown for three different time horizons. As the number of acute presentations tends to substantially increase from 10am, the negative impact on thrombolysis rate will be larger as the time horizon increases. The model output for the thrombolysis rate is relatively robust even in the most extreme case; the impact being an average reduction of only 1%. Even if the model has substantially underestimated the number of patients without a known time of onset in the early hours we can be confident that the pre-alert system retains the potential to exceed 13% if high compliance is observed. 
